BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 13, 2010
 |  BC Week In Review  |  Company News  |  Deals

Natco, Watson deal

Natco granted Watson exclusive, U.S. rights to develop and commercialize a generic version of lenalidomide 5, 10, 15 and 25 mg tablets. Natco submitted an ANDA in...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >